Physician profile
Jacquelyn Perry
NPI 1346200649
$7,352.20
in general payments reported to CMS, 2019-2025
32 companies · $838 in 2025
The $838 reported for 2025 was more than what 83% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,277 · 2020: $523 · 2021: $216 · 2022: $177 · 2023: $2,731 · 2024: $1,590 · 2025: $838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,889 · Travel and Lodging: $2,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,889.05 |
| Travel and Lodging | $2,270.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,623.08 | 2019-2024 | |
| Kerecis Limited | $1,163.07 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Treace Medical Concepts, INC. | $1,043.98 | 2019-2025 | |
| Trilliant Surgical LLC. | $643.44 | 2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Medshape, INC. | $403.00 | 2023 | Dynanail |
| Paratek Pharmaceuticals, INC. | $379.02 | 2021-2025 | Nuzyra |
| Amgen INC. | $334.14 | 2024-2025 | Krystexxa |
| Smith+Nephew, INC. | $280.83 | 2019-2023 | Renasys Go V2 Home |
| Melinta Therapeutics, LLC | $187.09 | 2019-2021 | |
| Pylant Medical | $159.47 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $151.16 | 2019 | |
| Paragon 28, INC. | $149.33 | 2025 | Portfolio |
| Nevro Corp. | $147.69 | 2023-2024 | Senza |
| Davol INC. | $114.62 | 2025 | Surgiphor |
| Organogenesis INC. | $98.07 | 2025 | Via Matrix |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $59.70 | 2020-2025 | Physio-Stim |
| Medtronic, INC. | $48.25 | 2022-2023 | Venaseal |
| Ethicon US, LLC | $42.94 | 2024 | Dermabond Prineo |
| Stryker Corporation | $34.72 | 2024 | N/A |
| Integra Lifesciences Corporation | $34.41 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $28.89 | 2025 | Exogen Ultrasound Bone Healing System |
| Arthrosurface Incorporated | $26.81 | 2025 | Toe Motiontm |
| Horizon Therapeutics Plc | $26.17 | 2023 | Krystexxa |
| Nabriva Therapeutics, Plc | $23.99 | 2021 | |
| Biowound Solutions, INC. | $23.43 | 2025 | Bio-Connekt |
| Depuy Synthes Sales INC. | $23.16 | 2021 | |
| Mimedx Group, INC. | $22.25 | 2025 | |
| Polynovo North America LLC | $19.60 | 2024 | Novosorb Btm |
| Averitas Pharma INC. | $17.93 | 2023 | Qutenza |
| Kci USA, INC. | $16.44 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $14.86 | 2025 | Exparel |
| Arteriocyte Medical Systems, INC. | $10.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.